Literature DB >> 34519539

Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue.

Julia Niessl1, Takuya Sekine1, Joshua Lange1, Viktoria Konya1, Marianne Forkel1, Jovana Maric1, Anna Rao1, Luca Mazzurana1, Efthymia Kokkinou1, Whitney Weigel1, Sian Llewellyn-Lacey2, Emma B Hodcroft3,4, Annika C Karlsson5, Johan Fehrm6,7, Joar Sundman6,7, David A Price2,8, Jenny Mjösberg1, Danielle Friberg9, Marcus Buggert1.   

Abstract

Cross-reactive CD4+ T cells that recognize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more commonly detected in the peripheral blood of unexposed individuals compared with SARS-CoV-2–reactive CD8+ T cells. However, large numbers of memory CD8+ T cells reside in tissues, feasibly harboring localized SARS-CoV-2–specific immune responses. To test this idea, we performed a comprehensive functional and phenotypic analysis of virus-specific T cells in tonsils, a major lymphoid tissue site in the upper respiratory tract, and matched peripheral blood samples obtained from children and adults before the emergence of COVID-19 (coronavirus disease 2019). We found that SARS-CoV-2–specific memory CD4+ T cells could be found at similar frequencies in the tonsils and peripheral blood in unexposed individuals, whereas functional SARS-CoV-2–specific memory CD8+ T cells were almost only detectable in the tonsils. Tonsillar SARS-CoV-2–specific memory CD8+ T cells displayed a follicular homing and tissue-resident memory phenotype, similar to tonsillar Epstein-Barr virus–specific memory CD8+ T cells, but were functionally less potent than other virus-specific memory CD8+ T cell responses. The presence of preexisting tissue-resident memory CD8+ T cells in unexposed individuals could potentially enable rapid sentinel immune responses against SARS-CoV-2.

Entities:  

Mesh:

Year:  2021        PMID: 34519539     DOI: 10.1126/sciimmunol.abk0894

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  20 in total

1.  Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply.

Authors:  Anthony T Tan; Nina Le Bert; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

Review 2.  Immune Senescence, Immunosenescence and Aging.

Authors:  Kyoo-A Lee; Rafael R Flores; In Hwa Jang; Ashley Saathoff; Paul D Robbins
Journal:  Front Aging       Date:  2022-05-30

Review 3.  Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.

Authors:  Ranjan Ramasamy
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

4.  SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection.

Authors:  Louise C Rowntree; Thi H O Nguyen; Lukasz Kedzierski; Melanie R Neeland; Jan Petersen; Jeremy Chase Crawford; Lilith F Allen; E Bridie Clemens; Brendon Chua; Hayley A McQuilten; Anastasia A Minervina; Mikhail V Pogorelyy; Priyanka Chaurasia; Hyon-Xhi Tan; Adam K Wheatley; Xiaoxiao Jia; Fatima Amanat; Florian Krammer; E Kaitlynn Allen; Sabrina Sonda; Katie L Flanagan; Jaycee Jumarang; Pia S Pannaraj; Paul V Licciardi; Stephen J Kent; Katherine A Bond; Deborah A Williamson; Jamie Rossjohn; Paul G Thomas; Shidan Tosif; Nigel W Crawford; Carolien E van de Sandt; Katherine Kedzierska
Journal:  Immunity       Date:  2022-06-08       Impact factor: 43.474

5.  Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.

Authors:  Yu Gao; Curtis Cai; David Wullimann; Julia Niessl; Olga Rivera-Ballesteros; Puran Chen; Joshua Lange; Angelica Cuapio; Ola Blennow; Lotta Hansson; Stephan Mielke; Piotr Nowak; Jan Vesterbacka; Mira Akber; Andre Perez-Potti; Takuya Sekine; Thomas R Müller; Caroline Boulouis; Tobias Kammann; Tiphaine Parrot; Jagadeeswara Rao Muvva; Michal Sobkowiak; Katie Healy; Gordana Bogdanovic; Sandra Muschiol; Gunnar Söderdahl; Anders Österborg; Fredrika Hellgren; Alba Grifoni; Daniela Weiskopf; Alessandro Sette; Karin Loré; Margaret Sällberg Chen; Per Ljungman; Johan K Sandberg; C I Edvard Smith; Peter Bergman; Hans-Gustaf Ljunggren; Soo Aleman; Marcus Buggert
Journal:  Immunity       Date:  2022-07-19       Impact factor: 43.474

6.  Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination.

Authors:  Aloysious Ssemaganda; Huong Mai Nguyen; Faisal Nuhu; Naima Jahan; Catherine M Card; Sandra Kiazyk; Giulia Severini; Yoav Keynan; Ruey-Chyi Su; Hezhao Ji; Bernard Abrenica; Paul J McLaren; T Blake Ball; Jared Bullard; Paul Van Caeseele; Derek Stein; Lyle R McKinnon
Journal:  Nat Commun       Date:  2022-06-10       Impact factor: 17.694

Review 7.  Mucosal immune responses to infection and vaccination in the respiratory tract.

Authors:  Robert C Mettelman; E Kaitlynn Allen; Paul G Thomas
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

Review 8.  Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology.

Authors:  Aaruni Khanolkar
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

Review 9.  SARS-CoV-2 infections in children: Understanding diverse outcomes.

Authors:  Petter Brodin
Journal:  Immunity       Date:  2022-01-20       Impact factor: 31.745

Review 10.  Human mucosal tissue-resident memory T cells in health and disease.

Authors:  Joshua Lange; Olga Rivera-Ballesteros; Marcus Buggert
Journal:  Mucosal Immunol       Date:  2021-11-06       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.